Table 1 The 13 patient cohorts (N = 1454) included in BC-BET. The numbers in the table correspond to the number of patients with each clinical characteristic or available endpoint that are included in the database and analyzed. A ‘-’ denotes insufficient sample size for analysis

AUH-1 [27] (GSE3167)

Affymetrix Human Genome U133A

9,41

8, 32

28, 13

–

–

–

50

AUH-2 [28]

(GSE5479)

MDL Human 3 k

–

98, 271

351, 51

–

–

–

404

Blaveri [14] (S)

UCSF Human Array 2.0

–

10, 68

27, 53

–

74

–

74

CNUH [29] (GSE13507)

Illumina human-6 v2.0

10, 165

105, 60

104, 61

165

165

–

175

DFCI [30] (GSE31684)

Affymetrix Human Genome U133 Plus 2.0

–

6, 84

15, 78

–

–

90

93

Lindgren [31] (GSE19915)

Swegene

12,144

72, 72

97, 45

–

142

–

156

Lindgren-2 [32] (GSE32548)

Illumina HumanHT-12 V3.0

–

56, 75

92, 38

–

89

–

131

MDA-1 [33] (GSE48276)

Illumina HumanHT-12 WG-DASL V4.0 R2

–

–

–

–

22^†

–

22

MDA-2 [33] (GSE48075)

Illumina HumanHT-12 V3.0

–

–

67, 73

–

73^†

–

140

MSKCC [15] (S)

Affymetrix Human Genome U133A

38,91

18, 73

25, 66

87

–

–

129

UVA [34] (GSE37317)

Affymetrix Human Genome U133A

–

–

8, 10

–

–

–

18

Stransky-1 [35] (E-TABM-147)

Affymetrix Human Genome U95A

5,26

11, 15

9, 17

–

–

–

31

Stransky-2 [35] (E-TABM-147)

Affymetrix Human Genome U95Av2

–

13, 16

16, 15

–

–

–

31

Total

74, 467

397, 769

839, 523

252

565

90

1454